Article Text

PDF
Razoxane - a new anti-tumour agent

Abstract

Razoxane (Razoxin - ICI; ICRF 159) is a new anti-tumour drug which is claimed to be well tolerated, to possess unusual modes of action and to increase the effectiveness of radiotherapy.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.